BioRestorative Therapies CEO Mark Weinreb Interviewed by The Life Sciences Report
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 07/25/13 -- "Millions of people suffer back pain caused by herniated and bulging disc disease. When conventional medical therapies fail, they often resort to surgery for relief, a costly and time-consuming solution for both patients and the medical system. In this interview with , Mark Weinreb, president, CEO and chairman of (OTCQB: BRTX), describes how his company's cell therapy process could keep disc disease treatment out of the operating theater.
: Mark, what disease indication are you exactly going after for patients suffering with back pain?
: We have developed a novel cellular therapy and therapeutic delivery device for the treatment of bulging and herniated disc disease. We believe we can effectively and safely treat patients using a nonsurgical, minimally invasive procedure that can be performed routinely in a physician's office. This technology could effectively bridge the gap between noninvasive and surgical back procedures. There are at least one million people, annually, in the U.S. who could benefit from this type of procedure with the promise of avoiding surgery. We elected to pursue this market because of the early success we have seen in several patients who have received this treatment.
: Can you very briefly describe the technology?"
Continue reading this interview with Mark Weinreb: "."
Read more about cell therapy and BioRestorative Therapies Inc. in The Life Sciences Report's in-depth interview with Jason Kolbert of Maxim Group: ""
Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that will help you capitalize on these developing trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.
Streetwise Reports, LLC - The Life Sciences Report
Brandon Fung
Email:
Tel: 707-981-8107
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 25.07.2013 - 17:59 Uhr
Sprache: Deutsch
News-ID 281932
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 261 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioRestorative Therapies CEO Mark Weinreb Interviewed by The Life Sciences Report"
steht unter der journalistisch-redaktionellen Verantwortung von
BioRestorative Therapies, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
